PitchSend

Popular
Blog
Companies
Finance
Technology
Banking
Information Technology
Oil and Energy
Internet
Mining and Metals
Communications
Real Estate
Biotechnology
Automotive
Medical
Retail
Energy
Investor Presentaiton slide image

Investor Presentaiton

Rigosertib in Patients with Recessive Dystrophic Epidermolysis Bullosa- associated SCC Investigator initiated trials: NCT03786237: Prof. Johann Bauer, EB House Austria, University Hospital Salzburg . NCT04177498: Dr. Neda Nikbakht, Thomas Jefferson University, PA 12 ClinicalTrials.gov 0 ONCONOVA THERAPEUTICS
View entire presentation

Product

HomeSearchAccount

Categories

Finance PresentationsTechnology PresentationsBanking PresentationsInformation Technology PresentationsOil and Energy PresentationsInternet PresentationsMining and Metals PresentationsCommunications PresentationsReal Estate PresentationsBiotechnology PresentationsAutomotive PresentationsMedical PresentationsRetail PresentationsEnergy Presentations

Company

InsightsContactSupport

Legal

Terms of ServicePrivacy Policy

Connect

TwitterLinkedInInstagramYouTube